A group of bipartisan legislators in New Mexico has introduced Senate Bill 219, aimed at establishing a medical psilocybin program for treating various mental health conditions. The bill, known as the "Medical Psilocybin Act," proposes to use psilocybin mushrooms for medical treatments of major treatment-resistant depression, post-traumatic stress disorder (PTSD), substance use disorders, end-of-life care, and other conditions approved by the Department of Health.

The act outlines the creation of a Medical Psilocybin Advisory Board to ensure safe administration in approved settings. It also includes provisions for a Medical Psilocybin Treatment Equity Fund to ensure fair access and a Research Fund to advance scientific understanding. Furthermore, it seeks to amend the Controlled Substances Act by removing psilocybin and psilocin from the schedule for qualified patients, clinicians, and producers under this program.

The proposed program is expected to be available by December 31, 2027, following rule-making processes by the Department of Health.

Senator Jeff Steinborn emphasized that "the Medical Psilocybin Act creates a carefully designed framework" and offers new hope for those facing serious behavioral health challenges. Senator Martin Hickey described it as "groundbreaking medical legislation" comparable to antibiotics' development. Senator Craig Brandt expressed optimism about offering effective treatment options for veterans like himself.

Representative Liz Thomson highlighted the need to explore promising treatments amid rising levels of mental health issues: "We owe it to those suffering." Representative Andrea Romero stated that New Mexico is leading innovation in mental health care with this legislation. Representative Stefani Lord pointed out research supporting psilocybin's therapeutic potential when used with licensed therapists.

Deborah Thorne, an integrative psychiatry provider in Las Cruces, supports the initiative: "The Medical Psilocybin Act will provide an equitable, safe and well-monitored means" while enhancing ongoing research efforts at UNM.

Senate Bill 219 will first be reviewed by the Senate Tax, Business & Transportation Committee.